Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 1, 2018
Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosisAndrew J Einstein, Igor Shuryak, Adam Castaño, et al.
Clinical Medicine Insights. Cardiology|June 9, 2021
Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient AdvocatesJose Nativi-Nicolau, Nitasha Sarswat, Johana Fajardo, et al.
The American Journal of Cardiology|January 13, 2022
Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service PopulationJamieson M Bourque, Alexander Schepart, Rahul Bhambri, et al.
Journal of Cardiac Failure|December 8, 2023
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid CardiomyopathyAdam Castaño, Stephen B Heitner, Ahmad Masri, et al.
Nature Communications|May 12, 2021
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathyAhsan Huda, Adam Castaño, Anindita Niyogi, et al.
Drug Design, Development and Therapy|March 29, 2021
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis StoryArianna Burton, Adam Castaño, Marianna Bruno, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 11, 2015
Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosisAdam Castaño, Albert DeLuca, Richard Weinberg, et al.
Pageof 4